BioCardia (BCDA)
(Delayed Data from NSDQ)
$1.81 USD
-0.15 (-7.65%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $1.79 -0.02 (-1.10%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, BioCardia, Inc. has a market cap of $10.79M, which represents its share price of $1.96 multiplied by its outstanding shares number of 5.50M. As a small-cap company, BCDA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BCDA 1.81 -0.15(-7.65%)
Will BCDA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BCDA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BCDA
Femasys Inc. (FEMY) Reports Q3 Loss, Tops Revenue Estimates
Urogen Pharma (URGN) Reports Q3 Loss, Tops Revenue Estimates
BCDA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Precision BioSciences (DTIL) Reports Q3 Loss, Misses Revenue Estimates
ChromaDex (CDXC) Beats Q3 Earnings and Revenue Estimates
MiMedx (MDXG) Q3 Earnings and Revenues Surpass Estimates
Other News for BCDA
BioCardia (BCDA) Eyes Regulatory Approvals for Key Cardiovascular Innovations
BioCardia provides update on plan seeking approval for CardiAMP and Helix
BioCardia (BCDA) Advances CardiAMP Cell Therapy in Japan | BCDA Stock News